![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, February 28, 2024 5:10:26 PM
If our float is as once reported, 229M shares, I believe that 110M (~90% of our OS) of those shares could be owned by Humanigen. That might be a whole lot of nothing, at a share price of $0.0001, or so, and no regulatory authorizations or approvals for lenz, and no customer demand.
But that could change instantly with news.
Pick a share price, if the brokerages are forced to buy-in shares, whether from a recall of the loaned shares, or a merger, and remember...the company owns most of the shares. So I'm hoping to sell some shares for about $200, especially if we're still on the Expert Market.
But, THERE'S SO MUCH POTENTIAL, that even if I can't sell at my target price, just our fundamental price could be in the $60 range ($8B, for example.) market cap, if we can get into the covid prevention market with the Novavax vaccine, and/or regulatory approval for CMML, not to mention a PRV, Humanigen could end up with a boat load of cash.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM